Looks to me like about a $.063 profit. Any reason why the report didn't clearly state that? I found it to be a little cryptic but it will all be flushed out tomorrow at the CC. Overall, I find it to be a HUGE improvement over the past mismanagement.
Overall it was a 6 cent/share profit. But operations lost a little under 6 cents ($3.316). They had a $6 million payment for the sale of Delatestryl and a $1.3 million payment from Abbott that are one time occurrences. That $7.3 million is almost $0.12/share. So the net of 6 cents is 12 cents on one time gains minus 6 cents on operating losses.